Actuate Therapeutics ACTU Ratios (2023-2026)

NASDAQ ACTU
$0.71 +0.02 (+3.47%)
As of: Sep 30, 2026 · 10:23 AM EDT
Reported Financials

Actuate Therapeutics Quarterly Ratios

Periods 12 quarters
Latest Jun 2026

Actuate Therapeutics ratios data for the quarter ended Jun 2026. These financial ratios cover 12 quarters of results from Jun 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Efficiency
Assets AverageAssets Avg. 8.00M11.79M6.90M5.73M12.34M15.87M9.62M
Equity AverageEquity Avg. -89.05M-95.88M-103.70M-111.02M-54.45M2.73M-2.49M-3.87M4.14M9.43M4.46M
Invested CapitalInvested Cap. -99.63M-107.36M
Leverage & Solvency
Interest Coverage RatioInterest Cover -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-926.21-969.11
Debt Ratio 3.99
Times Interest Earned -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-926.21-969.11
Valuation
Price to BookP/B 14.98639.6914.2217.9537.14
Enterprise Value 66.73M58.01M128.34M118.58M138.57M129.10M32.31M
Market Capitalization 80.26M66.65M132.23M125.07M155.50M142.26M36.74M
Return Ratios
Return on Capital Employed [ROCE]ROCE -842.03%-408.23%-221.24%-361.92%
Return on Assets [ROA]ROA -326.03%-211.67%-340.70%-419.63%-195.44%-140.02%-216.04%
Return on Equity [ROE]ROE -913.70%-582.43%-235.71%-466.22%

Actuate Therapeutics Ratios API

Pull Actuate Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ACTU&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY